MedTrace Logo

Menopausal Vaginal Microbiome

NCT05122065 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 432

Last updated 2021-11-24

No results posted yet for this study

Summary

In this study the investigators will analyze the vaginal microbiome of menopausal women in order to shed light on its potential implication on menopausal symptoms and quality of life. Moreover, the investigators will assess the effect of hormone replacement treatment on symptoms and overall quality of life during menopause and whether women under hormone replacement treatment have distinct vaginal microbiome profiles.

Conditions

  • Menopause
  • Hormone Replacement Therapy
  • Genitourinary Syndrome of Menopause

Sponsors & Collaborators

  • FemTec Health Inc.

    lead INDUSTRY

Principal Investigators

  • Kimberly Capone, PhD · FemTec Health Inc.

Eligibility

Min Age
40 Years
Max Age
70 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-12-01
Primary Completion
2022-02-28
Completion
2022-12-15

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05122065 on ClinicalTrials.gov